From an investment perspective, I’m really hoping to see an update from Generex that the company formally submitted their IND package to the FDA at the end of July, after all why would they enter into an agreement with a CRO a couple weeks ago unless on the cusp of starting Phase I hunan trials for the Ii-Key SARS Covid Vaccine?

I’m certainly displeased with aspects of how Generex communicates to shareholders, because in obvious proof I’ve had numerous shareholders known to me reach out over time saying that’s why they’ve sold and moved on. But I haven’t because I also appreciate the company, after not being supported by hundreds of millions or billions from the Government, never quit and moved on their own this far.

Love to hear IND submitted, waiting on the FDA 30 day period unless that is over, and SOLID RELIABLE information on the NGIO IPO that’s been extremely longer to undertake than ever noted by Generex management.